| Mr Bradley Gene Singer, MD | |
|
826 N Diers Ave, Grand Island, NE 68803-4955 | |
| (308) 708-2826 | |
| Not Available |
| Full Name | Mr Bradley Gene Singer |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 10 Years |
| Location | 826 N Diers Ave, Grand Island, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407054711 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Lanning Healthcare | Hastings, NE | Hospital |
| Chi Health St. Francis | Grand island, NE | Hospital |
| Entity Name | Heartland Pain Clinics, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700225331 PECOS PAC ID: 2567697428 Enrollment ID: O20131030001354 |
News Archive
Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel Cancer Center was found to detect over 90% of lung cancers in samples from nearly 800 individuals with and without cancer.
Mayo Clinic and the Translational Genomics Research Institute are helping launch a national clinical trial that will apply the latest in precision medicine to treat advanced melanoma skin cancer.
A groundbreaking technique developed at The University of Manchester, which uses crystals to map ‘invisible' parts of molecules, is set to revolutionise drug discovery.
BioTek's MultiFlo™ FX is now available with optional RAD™ (Random Access Dispense) technology to further extend its application range and flexibility. RAD technology offers single-channel dispensing to random individual microplate wells along with rapid reagent dispensing into large volume wells of 6- to 24- well microplates. MultiFlo FX can also be separately configured with an optional wash module for 6- to 384-well plates.
› Verified 3 days ago
| Entity Name | Total Body Pain Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174143267 PECOS PAC ID: 0749603439 Enrollment ID: O20200714002125 |
News Archive
Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel Cancer Center was found to detect over 90% of lung cancers in samples from nearly 800 individuals with and without cancer.
Mayo Clinic and the Translational Genomics Research Institute are helping launch a national clinical trial that will apply the latest in precision medicine to treat advanced melanoma skin cancer.
A groundbreaking technique developed at The University of Manchester, which uses crystals to map ‘invisible' parts of molecules, is set to revolutionise drug discovery.
BioTek's MultiFlo™ FX is now available with optional RAD™ (Random Access Dispense) technology to further extend its application range and flexibility. RAD technology offers single-channel dispensing to random individual microplate wells along with rapid reagent dispensing into large volume wells of 6- to 24- well microplates. MultiFlo FX can also be separately configured with an optional wash module for 6- to 384-well plates.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Bradley Gene Singer, MD Po Box 5492, Grand Island, NE 68802-5492 Ph: (308) 708-2826 | Mr Bradley Gene Singer, MD 826 N Diers Ave, Grand Island, NE 68803-4955 Ph: (308) 708-2826 |
News Archive
Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel Cancer Center was found to detect over 90% of lung cancers in samples from nearly 800 individuals with and without cancer.
Mayo Clinic and the Translational Genomics Research Institute are helping launch a national clinical trial that will apply the latest in precision medicine to treat advanced melanoma skin cancer.
A groundbreaking technique developed at The University of Manchester, which uses crystals to map ‘invisible' parts of molecules, is set to revolutionise drug discovery.
BioTek's MultiFlo™ FX is now available with optional RAD™ (Random Access Dispense) technology to further extend its application range and flexibility. RAD technology offers single-channel dispensing to random individual microplate wells along with rapid reagent dispensing into large volume wells of 6- to 24- well microplates. MultiFlo FX can also be separately configured with an optional wash module for 6- to 384-well plates.
› Verified 3 days ago